Objective:To describe the current evidence-based diagnosis and management of adenomyosis.

Target Population:All patients with a uterus of reproductive age.

Options:Diagnostic options include transvaginal sonography and magnetic resonance imaging.Treatment options should be tailored to symptoms(heavy menstrual bleeding,pain,and/or infertility)and include medical options(non-steroidal antiinflammatory drugs,tranexamic acid,combined oral contraceptives,levonorgestrel intrauterine system,dienogest,other progestins,gonadotropin-releasing analogues),interventional options(uterine artery embolization),and surgical options(endometrial ablation,excision of adenomyosis,hysterectomy).

Outcomes:Outcomes of interest include reduction in heavy menstrual bleeding,reduction in pelvic pain(dysmenorrhea,dyspareunia,chronic pelvic pain),and improvement in reproductive outcomes(fertility,miscarriage,adverse pregnancy outcomes).Benefits,Harms,and Costs:This guideline will benefit patients with gynaecological complaints that may be caused by adenomyosis,especially those patients who wish to preserve their fertility,by presenting diagnostic methods and management options.It will also benefit practitioners by improving their knowledge of various options.

目的：描述当前基于证据的子宫腺肌病诊断和治疗。

目标人群：所有育龄期子宫患者。选项：诊断选项包括经阴道超声和磁共振成像。

治疗选择应根据症状（月经量多、疼痛和/或不孕）进行调整，包括药物选择（非甾体类抗炎药、氨甲环酸、复方口服避孕药、左炔诺孕酮宫内节育系统、地诺孕素、其他孕激素、促性腺激素释放类似物）、介入治疗选择（子宫动脉栓塞）和手术选择（子宫内膜去除术、子宫腺肌病切除术、子宫切除术）。

结局：关注的结局包括减少月经量多、减轻盆腔疼痛（痛经、性交痛、慢性盆腔疼痛）、改善生育结局（生育、流产、不良妊娠结局）。受益、损害和成本：本指南将通过介绍诊断方法和治疗方案，使可能由子宫腺肌病引起的妇科主诉患者受益，尤其是希望保留生育能力的患者。它还将通过提高从业者对各种选择的知识而使其受益。